ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors).Clin Microbiol Infect. 2018 Feb 15. pii: S1198-743X(18)30182-4 [Epub ahead of print]. F.I.: 5.292

Inicio Repositorio ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors).Clin Microbiol Infect. 2018 Feb 15. pii: S1198-743X(18)30182-4 [Epub ahead of print]. F.I.: 5.292

2018/03

Autores/as:

Reinwald M, Silva JT, Mueller NJ, Fortún J, Garzoni C, de Fijter JW, Fernández-Ruiz M, Grossi P, Aguado JM

Servicio:

Enfermedades Infecciosas. Complejo Hospitalario Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen PubMed»,»link»:»https://www.ncbi.nlm.nih.gov/pubmed/29454849″}

info@areasaludbadajoz.com

Contacto

Salud

Información

Ciudadanos

info@areasaludbadajoz.com

Contacto

Salud​

Información​

Ciudadanos​

Salud

Información

Ciudadanos